A detailed history of Invenomic Capital Management LP transactions in Warby Parker Inc. stock. As of the latest transaction made, Invenomic Capital Management LP holds 383,877 shares of WRBY stock, worth $9.31 Million. This represents 0.36% of its overall portfolio holdings.

Number of Shares
383,877
Previous 342,767 11.99%
Holding current value
$9.31 Million
Previous $5.5 Million 13.95%
% of portfolio
0.36%
Previous 0.28%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$12.79 - $17.23 $525,796 - $708,325
41,110 Added 11.99%
383,877 $6.27 Million
Q2 2024

Aug 14, 2024

SELL
$11.74 - $17.71 $874,500 - $1.32 Million
-74,489 Reduced 17.85%
342,767 $5.5 Million
Q1 2024

May 15, 2024

BUY
$11.46 - $15.04 $1.99 Million - $2.61 Million
173,861 Added 71.43%
417,256 $5.68 Million
Q4 2023

Feb 14, 2024

BUY
$10.06 - $14.8 $2.45 Million - $3.6 Million
243,395 New
243,395 $3.43 Million

Others Institutions Holding WRBY

About Warby Parker Inc.


  • Ticker WRBY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 95,777,000
  • Market Cap $2.32B
  • Description
  • Warby Parker Inc. provides eyewear products. It offers eyeglasses, sunglasses, light-responsive lenses, blue-light-filtering lenses, and contact lenses, as well as accessories, including cases, lenses kit with anti-fog spray, pouches, and anti-fog lens spray. The company also offers eye exams and vision tests directly to consumers through its re...
More about WRBY
Track This Portfolio

Track Invenomic Capital Management LP Portfolio

Follow Invenomic Capital Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Invenomic Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Invenomic Capital Management LP with notifications on news.